the world's headlines, one feed
Actio Biosciences, which will receive $820 million up front in the deal, adds to a major upswing in private biotech buyouts seen throughout this year.
We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
In a first-of-its-kind study by King's College London, researchers have linked changes in two major types of immune cells in blood to different survival outcomes for patients with melanoma.
President Donald Trump and his Health Secretary Robert F. Kennedy Jr. have long tried to reduce the number of vaccinations available to the US public and even farm animals. The latest move in context.
President Donald Trump and his Health Secretary Robert F. Kennedy Jr. have long tried to reduce the number of vaccinations available to the US public and even farm animals. The latest move in context.
Indiana’s literacy rates exceeded pre-pandemic levels for the first time this year as the share of third grade students reaching proficiency on the state reading exam inched up to 88.7%.
Many Americans aren't getting enough exercise, but new research suggests it could help prevent cancer and other diseases.
Samsung has picked up FDA clearance in the US for a new hearing aid feature available on Galaxy Buds.